We report a case of a 67-year-old male patient with a sinonasal tumor that showed areas of classic biphenotypic sinonasal sarcoma (BSNS) which in some sections sharply transitioned into high-grade rhabdomyosarcoma. Immunohistochemically, the conventional BSNS parts showed S100 protein, SMA, PAX7, and focal MyoD1 expression, whereas desmin and myogenin were negative. In contrast, the cells in high-grade areas expressed desmin, MyoD1, myogenin, and PAX7, while being negative for S100 protein and SMA. Using the Archer FusionPlex assay, the classical PAX3::MAML3 gene fusion was detected. FISH for PAX3 and MAML3 confirmed a break of these genes in both components. Despite aggressive therapy, the tumor progression resulted in the patient's death. The herein presented case, together with 2 previously published cases of BSNS with high-grade transformation, helps to better understand this novel phenomenon. Although the risk for such transformation appears low, it has important clinical and diagnostic implications which are discussed.

Bioptical Laboratory Ltd Plzen Czech Republic

Department of Pathology Faculty of Medicine Charles University Medical Faculty and Charles University Hospital Plzen Alej Svobody 80 323 00 Plzen Czech Republic

Department of Pathology University of Kansas KS Kansas City USA

Medical Laboratory CSD Health Care Ltd Kyiv Ukraine

Zobrazit více v PubMed

Lewis JT, Oliveira AM, Nascimento AG, Schembri-Wismayer D, Moore EA, Olsen KD, et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–525. doi: 10.1097/PAS.0b013e3182426886. PubMed DOI

Carter CS, East EG, McHugh JB. Biphenotypic sinonasal sarcoma: a review and update. Arch Pathol Lab Med. 2018;142:1196–1201. doi: 10.5858/arpa.2018-0207-RA. PubMed DOI

Le Loarer F, Laffont S, Lesluyes T, Tirode F, Antonescu C, Baglin AC, et al. Clinicopathologic and molecular features of a series of 41 biphenotypic sinonasal sarcomas expanding their molecular spectrum. Am J Surg Pathol. 2019;43:747–754. doi: 10.1097/PAS.0000000000001238. PubMed DOI PMC

Fritchie KJ, Jin L, Wang X, Graham RP, Torbenson MS, Lewis JE, et al. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology. 2016;69:930–936. doi: 10.1111/his.13045. PubMed DOI

Huang SC, Ghossein RA, Bishop JA, Zhang L, Chen TC, Huang HY, et al. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol. 2016;40:51–59. doi: 10.1097/PAS.0000000000000492. PubMed DOI PMC

Wang X, Bledsoe KL, Graham RP, Asmann YW, Viswanatha DS, Lewis JE, et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet. 2014;46:666–668. doi: 10.1038/ng.2989. PubMed DOI PMC

Michal M, Rubin BP, Kazakov DV, Michalova K, Steiner P, Grossmann P, et al. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor. Virchows Arch. 2020;477:219–230. doi: 10.1007/s00428-020-02774-z. PubMed DOI

Georgantzoglou N, Green D, Stephen SA, Kerr DA, Linos K. Biphenotypic sinonasal sarcoma with PAX7 expression. Int J Surg Pathol. 2022;30:642–645. doi: 10.1177/10668969221080082. PubMed DOI

Nichols MM, Alruwaii F, Chaaban M, Cheng YW, Griffith CC (2022) Biphenotypic sinonasal sarcoma with a novel PAX3::FOXO6 fusion: a case report and review of the literature. Head Neck Pathol. 10.1007/s12105-022-01479-w PubMed PMC

Mechtersheimer G, Andrulis M, Delank KW, Volckmar AL, Zhang L, von Winterfeld M, et al. RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site? Genes Chromosom. Cancer. 2021;60:565–570. doi: 10.1002/gcc.22948. PubMed DOI PMC

Siegfried A, Romary C, Escudie F, Nicaise Y, Grand D, Rochaix P, et al. RREB1-MKL2 fusion in biphenotypic "oropharyngeal" sarcoma: new entity or part of the spectrum of biphenotypic sinonasal sarcomas? Genes Chromosom. Cancer. 2018;57:203–210. doi: 10.1002/gcc.22521. PubMed DOI

Agaimy A, Din NU, Dermawan JK, Haller F, Melzer K, Denz A, et al. RREB1::MRTFB fusion-positive extra-glossal mesenchymal neoplasms: a series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity. Genes Chromosom. Cancer. 2023;62:5–16. doi: 10.1002/gcc.23082. PubMed DOI PMC

Buckingham M, Relaix F. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol. 2007;23:645–673. doi: 10.1146/annurev.cellbio.23.090506.123438. PubMed DOI

Bell D, Phan J, DeMonte F, Hanna EY. High-grade transformation of low-grade biphenotypic sinonasal sarcoma: radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol. 2022;57:151889. doi: 10.1016/j.anndiagpath.2021.151889. PubMed DOI

Hasnie S, Glenn C, Peterson JEG, El Rassi ET, McKinney KA. High-grade biphenotypic sinonasal sarcoma: a case report. J Neurol Surg Rep. 2022;83:e105–e109. doi: 10.1055/s-0042-1755599. PubMed DOI PMC

Agaimy A, Dermawan JK, Leong I, Stoehr R, Swanson D, Weinreb I, et al. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck. Genes Chromosom. Cancer. 2022;61:701–709. doi: 10.1002/gcc.23083. PubMed DOI PMC

Charville GW, Varma S, Forgo E, Dumont SN, Zambrano E, Trent JC, et al. PAX7 Expression in rhabdomyosarcoma, related soft tissue tumors, and small round blue cell neoplasms. Am J Surg Pathol. 2016;40:1305–1315. doi: 10.1097/PAS.0000000000000717. PubMed DOI

Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol. 2002;9:198–203. doi: 10.1097/00125480-200205000-00003. PubMed DOI

Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities

Molecular pathology in diagnosis and prognostication of head and neck tumors